Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>A=Nakshatri, Harikrishna$<.>)
Общее количество найденных документов : 23
Показаны документы с 1 по 20
 1-20    21-23 
1.
Isolation of retinoic acid-repressed genes from P19 embryonal carcinoma cells // Gene, 1996. Vol. 174, N 1.-С.79-84

2.
Isolation of retinoic acid-repressed genes from P19 embryonal carcinoma cells // Gene, 1996. Vol. 174, N 1.-С.79-84

3.
Constitutive activation of NF-kB during progression of breast cancer to hormone-independent growth // Mol. and Cell. Biol., 1997. Vol. 17, N 7.-С.3629-3639

4.
NF-'каппа'B activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1'альфа' // Proc. Nat. Acad. Sci. USA, 1998. Vol. 95, N 12.-С.6971-6976

5.
NF-'каппа'B activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1'альфа' // Proc. Nat. Acad. Sci. USA, 1998. Vol. 95, N 12.-С.6971-6976

6.
Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells // Biochem. and Biophys. Res. Commun., 1999. Vol. 255, N 3.-С.703-706

7.
Negative regulation of transactivation function but not DNA binding of NF-'каппа'B and AP-1 by I'каппа'B'бета'1 in breast cancer cells // J. Biol. Chem., 1999. Vol. 274, N 26.-С.18827-18835

8.
Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer // Invest. New Drugs, 2004. Vol. 22, N 3.-С.299-305

9.
Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer // Invest. New Drugs, 2004. Vol. 22, N 3.-С.299-305

10.
Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model // Prostate, 2006. Vol. 66, N 14.-С.1498-1511

11.
Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model // Prostate, 2006. Vol. 66, N 14.-С.1498-1511

12.
A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-kB and generating reactive oxygen species // Int. J. Cancer, 2011. Vol. 128, N 10.-С.2481-2494

13.
A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-kB and generating reactive oxygen species // Int. J. Cancer, 2011. Vol. 128, N 10.-С.2481-2494

14.
A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-kB and generating reactive oxygen species // Int. J. Cancer, 2011. Vol. 128, N 10.-С.2481-2494

15.
A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-kB and generating reactive oxygen species // Int. J. Cancer, 2011. Vol. 128, N 10.-С.2481-2494

16.
Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain // J. Pathol., 2014. Vol. 232, N 3.-С.369-381

17.
Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain // J. Pathol., 2014. Vol. 232, N 3.-С.369-381

18.
Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA // Nature, 1988. Vol. 335, N 6193.-С.832-835

19.
Nakshatri Functional role of BK virus tumor antigens in transformation // J. Virol., 1988. Vol. 62, N 12.-С.4613-4621

20.
Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA // Nature, 1988. Vol. 335, N 6193.-С.832-835

 1-20    21-23 
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)